Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study

Our large real-world study confirms significant variability in CAB and RPV exposure, with BMI and sex as key predictors of lower Ctrough. Suboptimal CAB and RPV Ctrough, particularly in people with obesity, increases the risk of VF during the first year of treatment, highlighting the usefulness of TDM in clinical practice.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-07-18
DOI
https://doi.org/10.1093/cid/ciaf385
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study

Timothée Klopfenstein, Stéphane Bouchet, Anne Motte, François Parant et al.
Clinical Infectious Diseases
HIV Research and Treatment
article

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study

Timothée Klopfenstein, Stéphane Bouchet, Anne Motte, François Parant, Catherine Michel, Clément Javaux, Christina Psomas, Alexandre Destère, Patrice Muret, Cécile Mear-Passard, Clotilde Allavena, David Plainchamp, Antoine Asquier-Khati, Vincent Cálvez, Sébastien Lalanne, B. Bailly, Valentine Marie Ferré, Jade Ghosn, Axel Ursenbach, Vincent Gendrin, Jennifer Lagoutte‐Renosi, Olivia Faucher‐Zaegel, Thomas Drumel, François Bénézit, Matthieu Million, Caroline Solas, Nicolas Venisse, Laurent Hustache‐Mathieu, Marc‐Antoine Valantin, Yves Hansmann, Valérie Pourcher, Philippe Colson, F Bozon, Mary-Anne Trabaud, Gilles Peytavin, Matthieu Grégoire, Lio Collias, M. Santos, Dulce Alfaiate, Colin Deschanvres, Evelyne Braun, Peggy Gandia, Nadège Néant, Sophie Mahy, Philippe Flandre, Fabrice Bonnet, Baptiste Hoellinger, Camille Moyon, Florence M. Brunel, F. Lemaı̂tre, Souheil Zayet, Minh Lê, Cédric Arvieux, Cécile Brunet-Cartier, Anne‐Sophie Brunel, Catherine Dhiver, Amélie Menard, Yazdanpanah Yazdan, David Rey, Véronique Reliquet, Thomas Perpoint, Eric Billaud, Sylvie Brégigeon, Christine Cheneau, Diane Descamps, Bruno Hoën, Isabelle Ravaux, Sabelline Bouchez, C Mélounou, Agathe Becker, F. Raffi, Hélène Laroche, Patrick Philibert, Veronique Obry‐Roguet, Matthieu Godinot, Lionel Piroth, Michel Duong, Marielle Buisson, Christelle Tomei, Quentin Renou, Mojgane Hemssamfar, Simona-Loredana Berbescu, Gwennaelle Querne, Virginie Beslon
article en

Abstract

Our large real-world study confirms significant variability in CAB and RPV exposure, with BMI and sex as key predictors of lower Ctrough. Suboptimal CAB and RPV Ctrough, particularly in people with obesity, increases the risk of VF during the first year of treatment, highlighting the usefulness of TDM in clinical practice.

Clinical Infectious DiseasesVol. 82(1)
Université Claude Bernard Lyon 1 (FR), Délégation Paris 5 (FR), Inserm (FR), École Nationale Vétérinaire de Toulouse (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Université Paris Cité (FR), Aix-Marseille Université (FR), Centre Hospitalier Universitaire de Nice (FR), Centre Hospitalier Universitaire de Nantes (FR), Université de Poitiers (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Besançon (FR), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Sorbonne Paris Cité (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Bordeaux Population Health (FR), Institut de Recherche en Santé, Environnement et Travail (FR), Laboratoire de Thermique et Energie de Nantes (FR), Hôpital Pellegrin (FR), Laboratoire Jean-Alexandre Dieudonné (FR), Hôpital Lyon Sud (FR), Centre d'Investigation Clinique de Nantes (FR), Hôpital Bichat-Claude-Bernard (FR), Hôpital de la Timone (FR), Université Marie et Louis Pasteur (FR), Université Paris 1 Panthéon-Sorbonne (FR), Nantes Université (FR)
Agence Nationale de la Recherche, Agence Nationale de Recherches sur le Sida et les Hépatites Virales
Good health and well-being
Openalex Percentile: Top 77%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.